11.60 USD
↘ 0.20 (1.65%)AT CLOSE (03:59 PM EST)
Retension Pharmaceuticals, Inc. Common Stock
RTSNNASDAQ • USD
11.64
↗ 0.04 (0.39%)
POST MARKET (AS OF 04:19 PM EST)
Post Market
AS OF 04:19 PM EST
11.64
↗ 0.04 (0.39%)
Market: OPEN
Shares of Retension Pharmaceuticals, Inc. Common Stock (RTSN) are trading at $11.64. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Nov 4, 2026.
Open?$12.18
High?$12.80
Low?$11.40
Prev. Close?$11.79
Volume?153.1K
Avg. Volume?N/A
VWAP?$11.88
Bid / Ask
Bid?$15.00 × 200
Ask?$16.18 × 100
Spread?$1.18
Midpoint?$15.59
Valuation & Ratios
Market Cap?98.2M
Shares Out?N/A
Float?6.7M
Float %?80.8%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Retension Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product candidate, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 (PDE-5) inhibitor designed to reduce blood pressure.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.92%Low
Short Interest?62.0K
Days to Cover?1.0
Free Float6.7M
Avg Daily Volume118.2K
Settlement Date2026-10-15